AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
-4.37%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$446M
AUM Growth
+$446M
(-25%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-28.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
4
Closed
1
Top Buys
| 1 |
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
|
$5.68M |
Top Sells
| 1 |
Viridian Therapeutics
VRDN
|
$48.2M |
| 2 |
DraftKings
DKNG
|
$46.6M |
| 3 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$21.7M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
$12.5M |
| 5 |
Datadog
DDOG
|
$5.78M |
Sector Composition
| 1 | Consumer Discretionary | 76.05% |
| 2 | Healthcare | 16.89% |
| 3 | Communication Services | 7.05% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DraftKings
DKNG
$23.8B
| $339M | 76.05% | 7,284,008 -1,000,000 | -12% | -$46.6M |
|
|
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $49M | 10.98% | 2,656,517 -1,176,603 | -31% | -$21.7M |
|
3
Roku
ROKU
$14.2B
| $19.2M | 4.3% | 57,707 | – | – |
|
4
Snap
SNAP
$12.1B
| $12.3M | 2.76% | 245,559 | – | – |
|
|
BCYC
5
Bicycle Therapeutics
BCYC
$511M
| $11M | 2.47% | 612,696 -694,269 | -53% | -$12.5M |
|
6
Larimar Therapeutics
LRMR
$310M
| $6.26M | 1.4% | 292,184 | – | – |
|
|
FSTX
7
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $5.68M | 1.27% | +574,996 | New | +$5.68M |
|
|
8
Viridian Therapeutics
VRDN
$1.5B
| $3.45M | 0.77% | 209,505 -2,933,075 | -93% | -$48.2M |
|
|
9
Datadog
DDOG
$47.7B
| – | – | -56,616 | Closed | -$5.78M |
|